148 filings
Page 4 of 8
8-K
wjhq8hcwx 5w
27 Aug 19
Departure of Directors or Certain Officers
9:46pm
8-K
wptcpq
13 Aug 19
Termination of a Material Definitive Agreement
4:47pm
8-K
5qq4w1m3
6 Aug 19
Entry into a Material Definitive Agreement
1:17pm
8-K
xd052
30 Jul 19
Entry into a Material Definitive Agreement
5:25pm
8-K
3kj07t78 2b
14 Jun 19
Financial Statements and Exhibits
9:18pm
8-K
fw9u1cjpwv6pi8i5ii
20 May 19
Regulation FD Disclosure
1:06pm
8-K
gjuqv54haa84
30 Apr 19
Entry into a Material Definitive Agreement
5:09pm
8-K
u7g5bnc
31 Jan 19
Entry into a Material Definitive Agreement
4:17pm
8-K
s1gqgqhaqshm3iuquosr
11 Jan 19
Entry into a Material Definitive Agreement
3:32pm
8-K
6sdg4eykuuc
11 Jan 19
Entry into a Material Definitive Agreement
3:28pm
8-K
5nnbr06
27 Nov 18
Other Events
8:28am
8-K
b6q7 2jzc
16 Oct 18
Changes in Registrant's Certifying Accountant
3:55pm
8-K
6vfgn zb3x2h
15 Oct 18
Regulation FD Disclosure
5:03pm
8-K
3104za6hljwc x14k0m
1 Aug 18
Regulation FD Disclosure
8:30am
8-K
y1obokjj1vafow9ubw2
19 Jun 18
Departure of Directors or Certain Officers
4:01pm
8-K
n7y9lrptoj5a
16 May 18
Rezolute Announces Appointment of Keith Vendola as Chief Financial Officer
1:15pm
8-K
xk6bbod
9 Apr 18
Rezolute Announces Appointment of Congenital Hyperinsulinism Therapeutic Area Expert, Dr. Christine Ferrara, as Director of Clinical Development
12:00am
8-K
ifrq798fm9y9
4 Apr 18
Rezolute, Inc. Announces Appointment of Hoyoung Huh, M.D., Ph.D. as Vice Chairman of its Board of Directors
12:00am
8-K
e29dpy7nrueg9qgkqe
3 Apr 18
Rezolute, Inc. Announces Close of Convertible Note Financing
12:00am
8-K
4obfxxl
5 Feb 18
Entry into a Material Definitive Agreement
12:00am